524414 NORRIS

Norris Medicines Share Price

₹22.53 -0.45 (-1.96%)

02 Feb, 2025 10:42

SIP TrendupStart SIP in NORRIS

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 32.45%
  • Over 3 Month + 25.52%
  • Over 6 Month + 72.51%
  • Over 1 Year -12.33%
SIP Lightning

Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!

Invest Now

Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Norris Medicines Financials

Norris Medicines Technicals

EMA & SMA

Current Price
₹22.53
-0.45 (-1.96%)
pointer
  • stock-down_img
  • Bullish Moving Average 11
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • ₹21.95
  • 50 Day
  • ₹20.70
  • 100 Day
  • ₹19.48
  • 200 Day
  • ₹17.84

Resistance and Support

22.53 Pivot Speed
  • R3 22.53
  • R2 22.53
  • R1 22.53
  • S1 22.53
  • S2 22.53
  • S3 22.53

What's your outlook on Norris Medicines?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines has an operating revenue of Rs. 4.13 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -19% needs improvement, NULL It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Norris Medicines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-14 Quarterly Results
2023-12-29 Others Inter alia : 1. To Consider and approve Authorized Signatory for Bank Operations. 2. To Consider and recommend Mr. Vimal Shah as a Director of the Company subject to Members approval.

Norris Medicines F&O

Norris Medicines Shareholding Pattern

34.01%
0.01%
0.06%
20.71%
45.21%

About Norris Medicines

  • NSE Symbol
  • NORRIS
  • BSE Symbol
  • 524414
  • Managing Director
  • Mr. Vimal Shah
  • ISIN
  • INE744C01029

Similar Stocks to Norris Medicines

Norris Medicines FAQs

Norris Medicines share price is ₹22 As on 02 February, 2025 | 10:28

The Market Cap of Norris Medicines is ₹22.5 Cr As on 02 February, 2025 | 10:28

The P/E ratio of Norris Medicines is -27.4 As on 02 February, 2025 | 10:28

The PB ratio of Norris Medicines is -1.7 As on 02 February, 2025 | 10:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23